(18.222.200.143)
Users online: 13036     
Ijournet
Email id
 

Year : 2022, Volume : 46, Issue : 3
First page : ( 183) Last page : ( 192)
Print ISSN : 0250-4758. Online ISSN : 0973-970X. Published online : 2022  07.
Article DOI : 10.5958/0973-970X.2022.00031.1

Current Status of Bovine Ocular Squamous Cell Carcinoma

Pazhanivel Natesan1,*, Umarani R.2

1Department of Veterinary Pathology, Madras Veterinary CollegeChennai-600 007

2Teaching Veterinary Clinical ComplexVeterinary College and Research Institute

*Address for Correspondence, Dr Natesan Pazhanivel, Professor, Department of Veterinary Pathology, Madras Veterinary College, Chennai-600 007, E-mail: drnpvel@gmail.com

Online Published on 07 December, 2022.

Received:  15  April,  2022; Accepted:  12  August,  2022.

Abstract

Bovine ocular squamous cell carcinoma (BOSCC) is one of the important malignant neoplasms of cattle arising from squamous epithelium. The tumour was recorded at the age of three to eight years, and it affects most countries of the world. The possible etiologies include ultraviolet radiation, exposure to sunlight, nutrition, lack of pigmentation, bovine papilloma virus, increased altitude, decreased latitude, and hereditary and outdoor farming systems. Breeds of Hereford, Holstein, Jersey, Holstein cross and Jersey cross cattle are mostly affected, Common sites of the lower eyelid, third eyelid, limbus corneoscleral junction and cornea conjunctival junction were reported. Grossly the tumour is having plague, keratoma, papilloma and carcinoma formation. Cytological and histopathological appearance of BOSCC categorized as poorly differentiated squamous cell carcinoma, moderately squamous cell carcinoma and well differentiated squamous cell carcinoma. Immunohistochemistry using cytokeratin, MNF116, involucrin, P53, ki67 are the useful markers of BOSCC. Surgical extirpation is the choice of management of BOSCC and continued exposure to sunlight to be avoided to control this BOSCC.

Top

Keywords

BOSCC, Cytology, Etiology, Gross pathology, Histopathology, Immunohistochemistry, Treatment.

Top

 
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
745,725,628 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.